Invention Grant
- Patent Title: Polypeptides targeting vascular endothelial growth factor receptor-2 and alpha V beta 3 integrin
-
Application No.: US14510886Application Date: 2014-10-09
-
Publication No.: US09441026B2Publication Date: 2016-09-13
- Inventor: Jennifer R. Cochran , Adam Silverman , Douglas Jones , Niv Papo
- Applicant: The Board of Trustees of the Leland Stanford Junior University
- Applicant Address: US CA Stanford
- Assignee: The Board of Trustees of the Leland Standford Junior University
- Current Assignee: The Board of Trustees of the Leland Standford Junior University
- Current Assignee Address: US CA Stanford
- Agency: Bozicevic, Field & Francis LLP
- Agent Pamela J. Sherwood
- Main IPC: C07K14/515
- IPC: C07K14/515 ; C07K14/475 ; A61K38/18 ; A61K47/48
Abstract:
Polypeptides comprising variant vascular endothelial growth factor sequences are provided. The polypeptides are useful in cancer imaging, cancer diagnosis, monitoring and treatment as well as treatment of diseases characterized by excessive neovascularization.
Public/Granted literature
- US20150037888A1 Polypeptides Targeting Vascular Endothelial Growth Factor Receptor-2 and Alpha V Beta 3 Integrin Public/Granted day:2015-02-05
Information query
